Status:
COMPLETED
Persistence of Immune Response After Vaccination With Influenza Vaccine
Lead Sponsor:
Centers for Disease Control and Prevention, China
Conditions:
Influenza, Human
Immunisation Reaction
Eligibility:
All Genders
12-60 years
Phase:
NA
Brief Summary
This clinical study will be performed in subjects aged 12-60 years old enrolled in NCT01310374 who received 2010 seasonal influenza vaccine to evaluate the persistence of the immune response of influe...
Detailed Description
Subjects were previously vaccinated at 12 to 60 years of age with 2010 seasonal influenza vaccine.The persistence phase starts 24 months after the primary vaccination and blood samples will be taken a...
Eligibility Criteria
Inclusion
- aged 12-60 years old
- male or non-pregnant female
- volunteers received 2010 seasonal influenza vaccine
- clinically healthy as determined by: medical history inquiring and physical examination
- provide written informed consents before joining the trial
Exclusion
- without history of 2010 seasonal influenza vaccine administration,
- allergic to any ingredient of vaccine,
- autoimmune disease or immunodeficiency,
- severe adverse reaction after vaccination, such as allergies, hives, breathing difficulties, angioedema or abdominal pain,
- severe acute and chronic diseases
- axillary temperature over 37.0℃ at the time of vaccination.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT01906190
Start Date
August 1 2011
End Date
July 1 2013
Last Update
July 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuoketuo Centers for Disease Control & Prevention
Tuoketuo County, Inner Mongolia, China, 102000